Bioventix PLC (AIM:BVXP)

Bioventix Statistics

Total Valuation

Bioventix has a market cap or net worth of GBP 143.54 million. The enterprise value is 137.54 million.

Market Cap	143.54M
Enterprise Value	137.54M

Important Dates

The last earnings date was Tuesday, March 25, 2025.

Earnings Date	Mar 25, 2025
Ex-Dividend Date	Nov 7, 2024

Share Statistics

Bioventix has 5.22 million shares outstanding. The number of shares has increased by 0.14% in one year.

Current Share Class	n/a
Shares Outstanding	5.22M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	6.01%
Owned by Institutions (%)	67.24%
Float	4.15M

Valuation Ratios

The trailing PE ratio is 17.99 and the forward PE ratio is 16.08.

PE Ratio	17.99
Forward PE	16.08
PS Ratio	10.55
PB Ratio	11.96
P/TBV Ratio	11.96
P/FCF Ratio	17.24
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.81, with an EV/FCF ratio of 16.52.

EV / Earnings	16.99
EV / Sales	10.11
EV / EBITDA	12.81
EV / EBIT	12.94
EV / FCF	16.52

Financial Position

The company has a current ratio of 7.42

Current Ratio	7.42
Quick Ratio	4.37
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 67.29% and return on invested capital (ROIC) is 55.19%.

Return on Equity (ROE)	67.29%
Return on Assets (ROA)	49.17%
Return on Invested Capital (ROIC)	55.19%
Return on Capital Employed (ROCE)	88.53%
Revenue Per Employee	800,387
Profits Per Employee	476,278
Employee Count	17
Asset Turnover	1.01
Inventory Turnover	1.57

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.20% in the last 52 weeks. The beta is 0.42, so Bioventix's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-38.20%
50-Day Moving Average	2,920.30
200-Day Moving Average	3,660.80
Relative Strength Index (RSI)	45.13
Average Volume (20 Days)	6,730

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioventix had revenue of GBP 13.61 million and earned 8.10 million in profits. Earnings per share was 1.53.

Revenue	13.61M
Gross Profit	12.68M
Operating Income	10.63M
Pretax Income	10.60M
Net Income	8.10M
EBITDA	10.74M
EBIT	10.63M
Earnings Per Share (EPS)	1.53

Balance Sheet

The company has 6.00 million in cash and n/a in debt, giving a net cash position of 6.00 million or 1.15 per share.

Cash & Cash Equivalents	6.00M
Total Debt	n/a
Net Cash	6.00M
Net Cash Per Share	1.15
Equity (Book Value)	12.00M
Book Value Per Share	2.30
Working Capital	11.10M

Cash Flow

In the last 12 months, operating cash flow was 8.34 million and capital expenditures -15,907, giving a free cash flow of 8.33 million.

Operating Cash Flow	8.34M
Capital Expenditures	-15,907
Free Cash Flow	8.33M
FCF Per Share	1.60

Margins

Gross margin is 93.20%, with operating and profit margins of 78.10% and 59.51%.

Gross Margin	93.20%
Operating Margin	78.10%
Pretax Margin	77.92%
Profit Margin	59.51%
EBITDA Margin	78.93%
EBIT Margin	78.10%
FCF Margin	61.21%

Dividends & Yields

This stock pays an annual dividend of 1.55, which amounts to a dividend yield of 5.64%.

Dividend Per Share	1.55
Dividend Yield	5.64%
Dividend Growth (YoY)	1.97%
Years of Dividend Growth	1
Payout Ratio	101.86%
Buyback Yield	-0.14%
Shareholder Yield	5.50%
Earnings Yield	5.64%
FCF Yield	5.80%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bioventix has an Altman Z-Score of 80.96.

Altman Z-Score	80.96
Piotroski F-Score	n/a